论文信息 - Is spontaneous reporting always the most important information supporting drug withdrawals for pharmacovigilance reasons in France? - 字舞流文

Is spontaneous reporting always the most important information supporting drug withdrawals for pharmacovigilance reasons in France?

The objective of our study was to determine the nature of scientific evidence leading to drug withdrawal for safety reasons in France (between 2005 and 2011).

J. Montastruc | Jean-Louis Montastruc | Marie-Noelle Paludetto | Pascale Olivier-Abbal | Marie-Noëlle Paludetto | P. Olivier‐Abbal

[1] P. Mol,et al. A Decade of Safety-Related Regulatory Action in the Netherlands , 2010, Drug safety.

[2] M. Pirmohamed. Mechanisms of Adverse Drug Reactions , 2014 .

[3] J. Montastruc,et al. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France , 2006, Pharmacoepidemiology and drug safety.

[4] C. Codina,et al. The use of evidence in pharmacovigilance. Case reports as the reference source for drug withdrawals. , 2001, European journal of clinical pharmacology.

[5] Huub Schellekens,et al. Safety-related regulatory actions for biologicals approved in the United States and the European Union. , 2008, JAMA.

[6] S. Shakir,et al. An Assessment of the Publicly Disseminated Evidence of Safety Used in Decisions to Withdraw Medicinal Products from the UK and US Markets , 2006, Drug safety.

[7] Frantz Thiessard,et al. Trends in Spontaneous Adverse Drug Reaction Reports to the French Pharmacovigilance System (1986—2001) , 2005, Drug safety.

[8] J. Lexchin. Drug withdrawals from the Canadian market for safety reasons, 1963–2004 , 2005, Canadian Medical Association Journal.